Latest News

  • Kalbe Junior Scientist Awards 2012

    The Practice of Children’s Science Creativity Development in Elementary School

    Wednesday, April 18, 2012

    Jakarta, 18th April 2012 – PT Kalbe Farma Tbk (Kalbe) today kicked off the Kalbe Junior Scientist Award (KJSA) 2012 by holding an Education Seminar “The Practice of Children’s Science Creativity Development in Elementary School” at Peninsula Hotel, Jakarta. Promoting the theme “Innovation For A Better Life,” the KJSA event held for the second time since 2011 is purposed to nurturing Indonesian children’s love towards science from early age, thinking critically towards science and motivated to explore creativity in the form of a scientific invention.

  • Net Income for 2011 Grew by 15.2%

    Friday, March 30, 2012

    Jakarta, March 30, 2012 – PT Kalbe Farma Tbk (“Kalbe” or “the Company”) today announced the Company’s performance for the year 2011 based on Audited Consolidated Financial Statements for the year ending December 31, 2011 of PT Kalbe Farma Tbk and Subsidiaries.

  • Kalbe Launched Insulin Pumo

    The Latest Therapy for Diabetics

    Tuesday, March 27, 2012

    Jakarta, 27th March 2012 – Kalbe Group (Kalbe) today launched a variant of health equipment for diabetic patients, an insulin pump, which will be distributed under PT Enseval Medika Prima (EMP), one of Kalbe Group’s subsidiary operating in the healthcare equipment line.

  • Kalbe Inaugurated Generic Medicine Factory

    Health Minister inaugurated Generic Medicine Factory, producing 87 millions tablets/month

    Tuesday, February 28, 2012

    Cikarang, 28th February 2012 – Kalbe Group (Kalbe) today inaugurated the expansion of its generic medicine factory, PT Hexpharm Jaya in Cikarang. The inauguration was done by the Republic of Indonesia’s Health Minister, dr.Endang R. Sedyaningsih, MPH, Dr, PH. The factory which sits on a 13,295 m2 land took about Rp 150 billion in investment cost. In the future, this factory will have a production capacity of 87 million tablets monthly and absorb as much as 400 work forces.

  • Indicative Net Profit for 2011 Grew by Approximately 13.8%

    Thursday, February 16, 2012

    Jakarta, February 16, 2012 – PT Kalbe Farma Tbk (“Kalbe” or “the Company”) today announced the Company’s indicative performance for the year 2011. Kalbe recorded an indicative consolidated  net profit of Rp 1.46 Trillion for year 2011, an increase of approximately 13.8% compared to the Rp 1.28 Trillion figure for the same period last year. Earnings per share increased by approximately 13.8%, to Rp 156 per share from Rp 137 per share.